Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKinsey
Dow
Johnson and Johnson
Express Scripts
Baxter
Mallinckrodt

Last Updated: December 15, 2019

DrugPatentWatch Database Preview

Litigation Details for PFIZER INC. v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2004)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Small Molecule Drugs cited in PFIZER INC. v. TEVA PHARMACEUTICALS USA, INC.
The small molecule drugs covered by the patents cited in this case are   Start Trial and   Start Trial .

Details for PFIZER INC. v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2004)

Date Filed Document No. Description Snippet Link To Document
2004-02-19 1 Complaint infringement Of United States lelenl Nos. 5,466,823 (“the ‘823 patent"), 5,563,165 (“che ‘165 patenl”)…the ‘165 patent. A copy of the ‘165 patent is attached hereto as Exhibit B, 28, The ‘165 patent discloses…068 patent. A copy of the ‘068 patent is attached hereto as Exhibit C. 39. 'l`he ‘068 patent discloses…currently holds title to the ‘823 patent. A copy of the ‘823 patent is attached hereto as Exliibit A.…certification[] with respect to the `823 patent"). that the `823 patent is invalid. unenforceable and!or External link to document
2006-11-06 100 Opinion infringement of U.S. Patent Nos. 5,466,823; 5,563,165; and 5,760,068 (the “patents-in-suit”), which are…invention of the patent in suit by Dr. Len F. Lee, who was not an inventor of the patents-in-suit, and …(collectively “Pfizer” or “Plaintiffs”). The patents-in-suit are directed toward celecoxib, the active…comparisons to Celebrex. “One way for a patent [owner] to rebut a prima facie case of obviousness…the broad genus of compounds contained in another patent. Teva correctly points out that disclosure of External link to document
2006-11-06 102 Opinion infringement of U.S. Patent Nos. 5,466,823; 5,563,165; and 5,760,068 (the “patents-in-suit”), which are…and 8 of the ’823 patent, and composition claims 1-4, 15, and 16 of the ’165 patent cover deracoxib. …to be relied upon as a basis for patentability.”); Struthers Patent Corp. v. Nestle Co., 558 F. Supp…collectively “Pfizer” or “Plaintiffs”). The patents-in-suit are directed toward celecoxib, the active…367 F.3d 1381, 1385 (Fed. Cir. 2004). In Knoll, a patent holder offered evidence of the failure of two External link to document
2006-11-06 104 Opinion infringement of U.S. Patent Nos. 5,466,823; 5,563,165; and 5,760,068 (the “patents-in-suit”), which are…” because a “blocking patent” was in place. There is no such “blocking patent” in place here. Moreover…(collectively “Pfizer” or “Plaintiffs”). The patents-in-suit are directed toward celecoxib, the active…Roger Schechter and John Thomas, Principles of Patent Law 163 (2d ed.). This Court is bound by the Federal… Roger Schechter and John Thomas, Principles of Patent Law 163 (2d ed.); see also Truswal Sys. Corp. External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Baxter
Medtronic
Colorcon
McKesson
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.